Academy Publishes Treatment Guideline for Herpes Simplex Virus Keratitis

The Academy has released a clinical statement outlining the diagnosis and management of patients with Herpes simplex virus infection of the cornea. OMIC has identified several claims related to misdiagnosis or mismanagement of keratitis. We encourage policyholders to view the new guidelines to minimize risk and improve patient safety.

Herpes Simplex Virus Keratitis: A Treatment Guideline – 2014

Note: The Hoskins Center and Academy-approved clinical statements are developed without any external financial support. Authors and reviewers of Clinical Statements are volunteers and do not receive any financial compensation for their contributions to the documents.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.